Stock Taper 
GF FUND MANAGEMENT CO. LTD.
Latest 13F filing data - Q2 2026
Holdings
(Top positions)| STOCK | TICKER | SHARES HELD▲ ▼ | VALUE▲ ▼ |
|---|---|---|---|
 Berkshire Hathaway Inc. | BRK-B | 22 | $11.01K |
 Alexander's, Inc. | ALX | 34 | $9.37K |
 Saul Centers, Inc. | BFS | 185 | $6.92K |
 CME Group Inc. | CME | 200 | $44.17K |
 CBL & Associates Properties, Inc. | CBL | 210 | $11.15K |
 Centerspace | CSR | 229 | $12.87K |
 NexPoint Residential Trust, Inc. | NXRT | 275 | $7.68K |
 Inhibrx Biosciences Inc. | INBX | 312 | $29.56K |
 Rigel Pharmaceuticals, Inc. | RIGL | 381 | $14.9K |
 Innovative Industrial Properties, Inc. | IIPR | 381 | $23.61K |
 Tectonic Therapeutic, Inc. | TECX | 400 | $13.75K |
 Marsh & McLennan Companies, Inc. | MRSH | 415 | $69.17K |
 Ligand Pharmaceuticals Incorporated | LGND | 425 | $134.34K |
 Phibro Animal Health Corporation | PAHC | 440 | $13.82K |
 MP Materials Corp. | MP | 445 | $24.92K |
 ANI Pharmaceuticals, Inc. | ANIP | 477 | $39.49K |
 Madrigal Pharmaceuticals, Inc. | MDGL | 488 | $262.03K |
 The Goldman Sachs Group, Inc. | GS | 489 | $494.56K |
 argenx SE | ARGX | 546 | $506.56K |
 Eton Pharmaceuticals, Inc. | ETON | 569 | $20.6K |